Therefore, we recommend that when patients are diagnosed with suspected OI, they should be tested with high‐throughput multigene analysis, including that of the IFITM5 in order to obtain earlier diagnosis and treatment opportunities, no matter whether typical clinical manifestations have occurred or not. Here, IFITM5 is linked to osteogenesis imperfecta.